Description
In this video, Douglas Lucas discusses the significant role of hormones in bone health, focusing on estrogen, progesterone, and testosterone. He emphasizes the evidence supporting hormone replacement therapy (HRT) for osteoporosis and bone density, while addressing the controversies surrounding estrogen and the importance of understanding the risks and benefits of HRT. Lucas also explores the roles of progesterone and androgens like DHEA and testosterone, highlighting their potential benefits and the need for personalized treatment approaches. The conversation concludes with an invitation to join an HRT masterclass for further education on the topic.
Study Links:
https://pubmed.ncbi.nlm.nih.gov/33220453/
https://pubmed.ncbi.nlm.nih.gov/31237150/
https://www.nejm.org/doi/full/10.1056/NEJM199802193380801
https://pubmed.ncbi.nlm.nih.gov/17524997/
https://pubmed.ncbi.nlm.nih.gov/19434876/
https://pubmed.ncbi.nlm.nih.gov/37164187/
In this video, Douglas Lucas discusses the emerging ultrasound technology REMS in comparison to the traditional DEXA imaging for osteoporosis diagnosis. He highlights the importance of understanding accuracy, precision, and discordance in imaging results, emphasizing the potential of REMS for...
Published 10/14/24
In this video, Douglas Lucas discusses the complexities of hormone replacement therapy (HRT) for women with osteoporosis, particularly in the context of family history of breast cancer. He emphasizes the importance of understanding the risk-benefit equation when considering estrogen therapy,...
Published 10/09/24